Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway
about
Lyn kinase enhanced hepatic fibrosis by modulating the activation of hepatic stellate cells.β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.Role of moesin, Src, and ROS in advanced glycation end product-induced vascular endothelial dysfunction.Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruziSrc Plays an Important Role in AGE-Induced Endothelial Cell Proliferation, Migration, and Tubulogenesis.
P2860
Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@ast
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@en
type
label
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@ast
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@en
prefLabel
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@ast
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@en
P2093
P2860
P356
P1476
Carvedilol may attenuate liver ...... VEGF-Src-ERK signaling pathway
@en
P2093
Chun-Qing Zhang
Qi-Zhi Wang
Xiang-Guo Tian
P2860
P304
P356
10.3748/WJG.V21.I32.9566
P407
P577
2015-08-01T00:00:00Z